FFA
CLB icon

Farther Finance Advisors’s Core Laboratories CLB Stock Holding History

Farther Finance Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$135K Sell
13,912
-2,684
-16% -$31.1K ﹤0.01% 2614
2026
Q2 		$193K Buy
16,596
+2,641
+19% +$37.7K ﹤0.01% 2261
2026
Q1 		$225K Buy
13,955
+4,010
+40% +$71.7K ﹤0.01% 1938
2025
Q4 		$159K Buy
9,945
+6,033
+154% +$89.8K ﹤0.01% 2060
2025
Q3 		$48.4K Buy
3,912
+43
+1% +$504 ﹤0.01% 2460
2025
Q2 		$44.6K Sell
3,869
-19,997
-84% -$237K ﹤0.01% 2191
2025
Q1 		$358K Hold
23,866
– – 0.01% 950
2024
Q4 		$413K Hold
23,866
– – 0.01% 665
2024
Q3 		$442K Sell
23,866
-1,718
-7% -$34.5K 0.02% 642
2024
Q2 		$511K Buy
25,584
+5,718
+29% +$101K 0.02% 473
2024
Q1 		$340K Buy
19,866
+13,197
+198% +$208K 0.02% 488
2023
Q4 		$118K Buy
6,669
+2,669
+67% +$53.8K 0.01% 736
2023
Q3 		$96K Hold
4,000
– – 0.02% 573
2023
Q2 		$93K Hold
4,000
– – 0.02% 487
2023
Q1 		$88.2K Buy
+4,000
New +$93.6K 0.03% 435

Other funds holding CLB

HCA
Harpswell Capital Advisors Yarmouth, Maine $152M AUM 8.39% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's CLB Position: Q3 2026 in Review

Farther Finance Advisors reduced its Core Laboratories (CLB) stake by 16% in Q3 2026, selling an estimated $31.1K and leaving 13,912 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #2614.

Farther Finance Advisors first reported a position in CLB in Q1 2023 and has held it in 15 quarters since. The position peaked at $511K in Q2 2024. 4 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • Farther Finance Advisors held 13,912 shares of Core Laboratories worth $135K as of Q3 2026.
  • Farther Finance Advisors sold 2,684 Core Laboratories shares in Q3 2026, an estimated $31.1K.
  • Core Laboratories made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2614 holding.
  • Farther Finance Advisors first reported a position in Core Laboratories in Q1 2023 and has held it in 15 quarters since.
  • Farther Finance Advisors's Core Laboratories position peaked at $511K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.